Tenax Therapeutics, Inc. · NASDAQ:TENX

BVF PARTNERS L P/IL reported a 9.99% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

BVF PARTNERS L P/IL reported a 9.99% stake in Tenax Therapeutics, Inc., 768,200 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
768,200
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P7.80%596,433
BVF I GP LLC7.80%596,433
BIOTECHNOLOGY VALUE FUND II LP2.30%165,382
BVF II GP LLC2.30%165,382
Biotechnology Value Trading Fund OS LP0%0
BVF Partners OS Ltd.0%0
BVF GP HOLDINGS LLC9.90%761,815
BVF PARTNERS L P/IL9.99%768,200
BVF INC/IL9.99%768,200
LAMPERT MARK N9.99%768,200

Source

View original at SEC

Related